Are autism drugs on the horizon?
Researchers at the Hebrew University of Jerusalem have identified a genetic mutation associated with autism, offering fresh hope for effective therapeutics. Genetic mutations have a strong effect on […]
Researchers at the Hebrew University of Jerusalem have identified a genetic mutation associated with autism, offering fresh hope for effective therapeutics. Genetic mutations have a strong effect on […]
Most people hospitalised with COVID-19 have at least one symptom six months after falling ill, according to a follow-up study of people in Wuhan China. The cohort study […]
The European Medicines Agency gave its backing to 15 new medicines at its December meeting, taking its total for the year to 96. This rounded off a busy […]
The European Medicines Agency (EMA) has confirmed that health authorities can extract six doses of vaccine from each vial of Comirnaty, a vaccine against COVID-19 manufactured by Pfizer/BioNTech. […]
A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases to controls with similar medical histories. The […]
The findings of a recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) could have important implications for practice, according to lead researcher Dr […]
A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr Mark Tatangelo, the lead researcher explains. This study […]
Rheumatoid arthritis (RA) affects about one percent of the population in the UK and comorbidities are reported to be common. A recent study from Canada was designed to […]
Among persons with prediabetes, a lifestyle intervention can almost halve the risk of developing Type 2 diabetes, researchers from a large, new study reported on Nov. 13, 2020 […]
Investigators from the QUAZAR trial report that treatment with oral azacytidine (CC-486), significantly improves survival in older patients, over age of 55, with AML acute myeloid leukemia (AML). […]
The diabetes drug canagliflozin, which has already shown efficacy in slowing kidney disease, is also effective among patients with advanced kidney disease. Researchers reported these findings in the […]
Rilonacept, an FDA approved drug for other inflammatory diseases, shows high efficacy for treating acute pericarditis, an inflammation of tissue around the heart. The findings were published on […]